Biotech Insight podcast: Overcoming planning challenges in oncologyThe first episode of Kantar Health’s new Biotech Insight podcast takes aim at the planning and forecasting challenges Share XBiotech Insight podcast: Overcoming planning challenges in oncologyhttps://pharmaphorum.com/podcast/biotech-insight-oncology-planning/
Prof Nigel Osborne: Science is catching up with ‘medical music’The internationally recognised composer, peace worker and musical therapy pioneer tells pharmaphorum how his emerging field stands at Share XProf Nigel Osborne: Science is catching up with ‘medical music’https://pharmaphorum.com/patients/professor-nigel-osborne-medical-music/
External control arms and debunking real-world data mythsFor the healthcare ecosystem to drive research and care, clarity is needed about the opportunities and challenges of Share XExternal control arms and debunking real-world data mythshttps://pharmaphorum.com/r-d/external-control-arms-real-world-data/
Amplifying the patient voice for better engagement, recruitment and retentionEveryone is familiar with the phrase ‘patient-centricity’ but, where it might once have been seen as a ‘checkbox Share XAmplifying the patient voice for better engagement, recruitment and retentionhttps://pharmaphorum.com/r-d/clinical-trials-patient-voice-prime-global/
Vertex’s Nicola Massey: the pharmaphorum podcastIn the latest episode of the podcast Dominic Tyer speaks with Nicola Massey, who’s Vertex’s senior country manager Share XVertex’s Nicola Massey: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/vertex-senior-country-manager-nicola-massey/
Organicell on regenerative medicine: the pharmaphorum podcastIn the latest episode of the podcast Dominic Tyer speaks with Dr Maria Ines ‘Mari’ Mitrani, chief science officer Share XOrganicell on regenerative medicine: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/organicell-regenerative-medicine-covid
Pharmacy and clinical research: the pharmaphorum podcastIn the latest episode of the pharmaphorum podcast, pharmaphorum’s web editor Catherine Longworth speaks to Gerald Finken, the founder Share XPharmacy and clinical research: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/pharmacy-clinical-research-rxe2/
Pharma’s post-COVID prospects: the pharmaphorum podcastIn this latest podcast, pharmaphorum spoke to Andrew Meade, life sciences lead UK and Ireland at Accenture, about Share XPharma’s post-COVID prospects: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/pharma-post-covid-prospects-accenture/
performance-io adds Jason McKenna as a non-executive directorUK-based performance-io has added to its senior team through two promotions and the appointment of STEM Healthcare CEO Share Xperformance-io adds Jason McKenna as a non-executive directorhttps://pharmaphorum.com/news/performance-io-leadership-jason-mckenna/
